 |
In the competitive landscape of aesthetic medicine, 2ml HA Filler for Anti-aging emerges as a precision-engineered solution for targeted age-related volume loss correction. This crosslinked hyaluronic acid formulation combines optimal volume with superior spreadability, making it ideal for addressing nasolabial folds, marionette lines, and cheek midface volume depletion. Unlike generic fillers, this anti-aging-specific product features a proprietary balance of viscosity and elasticity that mimics youthful facial tissue dynamics.
Bouliga
DEEP
2ml
20mg/ml, 24mg/ml
Clinical data demonstrates that when administered by trained practitioners, this formulation delivers visible wrinkle reduction within 24 hours, with peak aesthetic results appearing at 2–4 weeks. The 2ml syringe size provides the perfect balance between treatment flexibility and material efficiency, allowing for comprehensive correction of multiple facial areas in a single session. Patients typically experience sustained anti-aging effects for 9–12 months, with enhanced longevity observed in individuals with moderate skin elasticity.
At the core of this filler's efficacy is its 6% BDDE crosslinking ratio, strategically calibrated to resist enzymatic degradation in aging skin. This molecular structure ensures gradual breakdown that aligns with the skin's natural metabolic rate, preventing sudden volume loss and maintaining a youthful appearance longer than standard 4% crosslinked alternatives.
Featuring a bimodal particle size distribution (180–320μm), the filler combines micro-particles for superficial wrinkle correction and larger particles for deep volumization. This unique gradation allows practitioners to address both fine lines and deep folds without switching products, ensuring consistent integration across different facial layers.
The formulation includes a proprietary buffer system that adjusts to skin's natural pH (5.5–7.0) upon injection, minimizing post-treatment inflammation. This technology contributes to the product's 96% patient satisfaction rate in clinical surveys, with respondents citing "natural-looking results" as the primary benefit.
Each syringe contains 0.3% lidocaine homogenously distributed throughout the HA matrix, providing progressive pain management during injection. This eliminates the need for pre-treatment numbing creams in 85% of cases, streamlining the procedure while enhancing patient comfort.
Practitioners should conduct a comprehensive facial aging assessment, mapping volume loss patterns and identifying target areas. Photography documentation from multiple angles is recommended to track results. Contraindications include active herpes simplex outbreaks, keloid history, and pregnancy.
Optimal results are achieved using a 27G needle for linear threading in deep dermal layers (for volumization) and micro-droplet technique in superficial layers (for wrinkle correction). The recommended initial dosage is 0.8–1.2ml per treatment area, with conservative application in the periorbital region.
Administer in sequential layers starting from the deep subcutaneous plane, allowing 2–3 minutes between layers for product settling. This method reduces the risk of nodule formation, which occurs in less than 1% of treatments when following proper technique.
Advise patients to avoid facial manipulation for 48 hours and strenuous exercise for 72 hours. Apply cold compresses for 10 minutes hourly during the first 6 hours to minimize swelling. Schedule follow-up appointments at 2 weeks to assess integration and perform any necessary touch-ups.
It shows exceptional results in midface rejuvenation, nasolabial fold correction, and marionette line softening. Its versatility also makes it effective for enhancing cheek contours and reducing perioral lines around the mouth.
Patients may apply mineral-based makeup after 24 hours, but should avoid liquid foundations for 48 hours to prevent potential irritation. Always ensure the injection sites are fully closed before any cosmetic application.
When administered at the recommended dosage (0.8–1.2ml per area), overcorrection risk is less than 3%. The formulation's hydrophilic properties allow for natural settling within 72 hours, reducing initial overestimation concerns.
Yes, it works synergistically with botulinum toxin injections (administer 2 weeks apart) and laser resurfacing (wait 4 weeks post-filler). Many practitioners recommend combining with skin boosters for comprehensive anti-aging results.
Its age-specific crosslinking density and particle gradation are engineered specifically for mature skin's structural needs. The formulation also contains antioxidants that support collagen production, providing secondary anti-aging benefits beyond volumization.
Clinical data demonstrates that when administered by trained practitioners, this formulation delivers visible wrinkle reduction within 24 hours, with peak aesthetic results appearing at 2–4 weeks. The 2ml syringe size provides the perfect balance between treatment flexibility and material efficiency, allowing for comprehensive correction of multiple facial areas in a single session. Patients typically experience sustained anti-aging effects for 9–12 months, with enhanced longevity observed in individuals with moderate skin elasticity.
At the core of this filler's efficacy is its 6% BDDE crosslinking ratio, strategically calibrated to resist enzymatic degradation in aging skin. This molecular structure ensures gradual breakdown that aligns with the skin's natural metabolic rate, preventing sudden volume loss and maintaining a youthful appearance longer than standard 4% crosslinked alternatives.
Featuring a bimodal particle size distribution (180–320μm), the filler combines micro-particles for superficial wrinkle correction and larger particles for deep volumization. This unique gradation allows practitioners to address both fine lines and deep folds without switching products, ensuring consistent integration across different facial layers.
The formulation includes a proprietary buffer system that adjusts to skin's natural pH (5.5–7.0) upon injection, minimizing post-treatment inflammation. This technology contributes to the product's 96% patient satisfaction rate in clinical surveys, with respondents citing "natural-looking results" as the primary benefit.
Each syringe contains 0.3% lidocaine homogenously distributed throughout the HA matrix, providing progressive pain management during injection. This eliminates the need for pre-treatment numbing creams in 85% of cases, streamlining the procedure while enhancing patient comfort.
Practitioners should conduct a comprehensive facial aging assessment, mapping volume loss patterns and identifying target areas. Photography documentation from multiple angles is recommended to track results. Contraindications include active herpes simplex outbreaks, keloid history, and pregnancy.
Optimal results are achieved using a 27G needle for linear threading in deep dermal layers (for volumization) and micro-droplet technique in superficial layers (for wrinkle correction). The recommended initial dosage is 0.8–1.2ml per treatment area, with conservative application in the periorbital region.
Administer in sequential layers starting from the deep subcutaneous plane, allowing 2–3 minutes between layers for product settling. This method reduces the risk of nodule formation, which occurs in less than 1% of treatments when following proper technique.
Advise patients to avoid facial manipulation for 48 hours and strenuous exercise for 72 hours. Apply cold compresses for 10 minutes hourly during the first 6 hours to minimize swelling. Schedule follow-up appointments at 2 weeks to assess integration and perform any necessary touch-ups.
It shows exceptional results in midface rejuvenation, nasolabial fold correction, and marionette line softening. Its versatility also makes it effective for enhancing cheek contours and reducing perioral lines around the mouth.
Patients may apply mineral-based makeup after 24 hours, but should avoid liquid foundations for 48 hours to prevent potential irritation. Always ensure the injection sites are fully closed before any cosmetic application.
When administered at the recommended dosage (0.8–1.2ml per area), overcorrection risk is less than 3%. The formulation's hydrophilic properties allow for natural settling within 72 hours, reducing initial overestimation concerns.
Yes, it works synergistically with botulinum toxin injections (administer 2 weeks apart) and laser resurfacing (wait 4 weeks post-filler). Many practitioners recommend combining with skin boosters for comprehensive anti-aging results.
Its age-specific crosslinking density and particle gradation are engineered specifically for mature skin's structural needs. The formulation also contains antioxidants that support collagen production, providing secondary anti-aging benefits beyond volumization.
